The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Open accessAbstract
Diabetic retinopathy diagnostic assessment and treatment options have improved dramatically since the 2002 American Diabetes Association Position Statement (1). These improvements include the widespread adoption of optical coherence tomography to assess retinal thickness and intraretinal pathology and wide-field fundus photography to reveal clinically silent microvascular lesions. Treatment of diabetic macular edema is now achieved by intravitreous injection of anti–vascular endothelial growth factor agents, and the same drugs are now used for proliferative diabetic retinopathy. Improvements in medications and devices for the systemic therapy of diabetes have also improved the ability of patients to optimize their metabolic control. This Position Statement incorporates these recent developments for the use of physicians and patients. Diabetic retinopathy is a highly specific neurovascular complication of both type 1 and type 2 diabetes, the prevalence of which strongly correlates to both the duration of diabetes and level of glycemic control. A pooled meta-analysis involving 35 studies conducted worldwide from 1980 to 2008 estimated global prevalence of any diabetic retinopathy and proliferative diabetic retinopathy (PDR) among patients to be 35.4% and 7.5%, respectively (2). Diabetic retinopathy is the most frequent cause of new cases of blindness among adults aged 20–74 years in developed countries. Glaucoma, cataracts, and other disorders of the eye occur earlier and more frequently in people with diabetes. In addition to diabetes duration, factors that increase the risk of or are associated with retinopathy include chronic hyperglycemia (3,4), nephropathy (5), hypertension (6), and dyslipidemia (7). Intensive diabetes management with the goal of achieving near-normoglycemia has been shown in large prospective randomized studies to prevent and/or delay the onset and progression of diabetic retinopathy (8,9). Lowering blood pressure has been shown to decrease retinopathy progression in people with type 2 diabetes, although tight targets (systolic blood pressure <120 mmHg) do …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,802
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
Ranibizumab for Diabetic Macular Edema
Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.039 · Cited by 1,621
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,477
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Self-citationMitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Keech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109
Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross, J. G., Glassman, A. R., Jampol, L. M., Inusah, S., Aiello, L. P., Antoszyk, A. N., Baker, C. W., Berger, B. B., Bressler, N. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.15217 · Cited by 784
Self-citationPreliminary Report on Effects of Photocoagulation Therapy
(1976) · American Journal of Ophthalmology · doi:10.1016/0002-9394(76)90292-0 · Cited by 723
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII
Klein, R., Knudtson, M. D., Lee, K. E., Gangnon, R., & Klein, B. E. K. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.023 · Cited by 584
Elman, M. J., Bressler, N. M., Qin, H., Beck, R. W., Ferris, F. L., Friedman, S. M., Glassman, A. R., Scott, I. U., Stockdale, C. R., & Sun, J. K. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.033 · Cited by 573
Self-citationAiello, L. P., Gardner, T. W., King, G. L., Blankenship, G., Cavallerano, J. D., Ferris, F. L., & Klein, R. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.143 · Cited by 508
Self-citationKlein, R. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090210105023 · Cited by 486
Klein, R. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010243030 · Cited by 470
(1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30973-6 · Cited by 446
Metabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study
Chew, E. Y., Mills, J. L., Metzger, B. E., Remaley, N. A., Jovanovic-Peterson, L., Knopp, R. H., Conley, M., Rand, L., Simpson, J. L., Holmes, L. B., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.631 · Cited by 402
Self-citationHow Effective Are Treatments for Diabetic Retinopathy?
Ferris, F. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500100088034 · Cited by 392
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Chew, E. Y., Davis, M. D., Danis, R. P., Lovato, J. F., Perdue, L. H., Greven, C., Genuth, S., Goff, D. C., Leiter, L. A., Ismail-Beigi, F., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.07.019 · Cited by 324
Self-citationSun, J. K., Radwan, S. H., Soliman, A. Z., Lammer, J., Lin, M. M., Prager, S. G., Silva, P. S., Aiello, L. B., & Aiello, L. P. (2015) · Diabetes · doi:10.2337/db14-0782 · Cited by 217
Self-citationThe 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus
Klein, R., Lee, K. E., Gangnon, R. E., & Klein, B. E. K. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.06.051 · Cited by 181
Blood pressure control for diabetic retinopathy
Diana, V., Wang, X., Vedula, S. S., Marrone, M. T., Sleilati, G. G., Hawkins, B. S., & Frank, R. N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006127.pub2 · Cited by 179
Cost Effectiveness of Current Approaches to the Control of Retinopathy in Type I Diabetics
Javitt, J. C., Canner, J. K., & Sommer, A. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32923-x · Cited by 177
Gunderson, E. P., Lewis, C. E., Tsai, A.-L., Chiang, V., Carnethon, M., Quesenberry, C. P., & Sidney, S. (2007) · Diabetes · doi:10.2337/db07-1024 · Cited by 164
Ahmed, J., Ward, T. P., Bursell, S.-E., Aiello, L. M., Cavallerano, J. D., & Vigersky, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-0295 · Cited by 152
Kırkızlar, E., Serban, N., Sisson, J. A., Swann, J., Barnes, C. S., & Williams, M. D. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.06.029 · Cited by 148
Diabetic Retinopathy during Pregnancy
Axer‐Siegel, R., Hod, M., Fink‐Cohen, S., Kramer, M., Weinberger, D., Schindel, B., & Yassur, Y. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30421-1 · Cited by 136
Screening for Presence or Absence of Diabetic Retinopathy: A Meta-analysis
Bragge, P. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.319 · Cited by 134
Predicting Development of Proliferative Diabetic Retinopathy
Nwanyanwu, K. H., Talwar, N., Gardner, T. W., Wrobel, J. S., Herman, W. H., & Stein, J. D. (2012) · Diabetes Care · doi:10.2337/dc12-0790 · Cited by 131
Self-citationOvert albuminuria predicts diabetic retinopathy in Hispanics with NIDDM
Estacio, R., McFARLING, E. T., Biggerstaff, S. L., Jeffers, B. W., Johnson, D., & Schrier, R. W. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9631838 · Cited by 117
Agardh, E., & Tababat-Khani, P. (2011) · Diabetes Care · doi:10.2337/dc10-2308 · Cited by 113
Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes
The DCCT/EDIC Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409463 · Cited by 112
Leske, M. C., WU, S., Hennis, A. J. M., Hyman, L., Nemesure, B. B., Yang, L., & SCHACHAT, A. P. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.054 · Cited by 106
Blood pressure control for diabetic retinopathy
Diana, V., Wang, X., Vedula, S. S., Marrone, M., Sleilati, G. G., Hawkins, B. S., & Frank, R. N. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 106
Kajiwara, A., Miyagawa, H., Saruwatari, J., Kita, A., Sakata, M., Kawata, Y., Oniki, K., Yoshida, A., Jinnouchi, H., & Nakagawa, K. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.043 · Cited by 87
Ten-Year Cumulative Incidence of Diabetic Retinopathy. The Beijing Eye Study 2001/2011
Xu, J., Xu, L., Wang, Y. X., You, Q. S., Jonas, J. B., & Wei, W. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111320 · Cited by 87
Cost-Effectiveness of Treatment of Diabetic Macular Edema
Pershing, S., Enns, E. A., Matesic, B., Owens, D. K., & Goldhaber‐Fiebert, J. D. (2014) · Annals of Internal Medicine · doi:10.7326/m13-0768 · Cited by 74
The 5-Year Onset and Regression of Diabetic Retinopathy in Chinese Type 2 Diabetes Patients
Jin, P., Peng, J., Zou, H., Wang, W., Fu, J., Shen, B., Bai, X., Xu, X., & Zhang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113359 · Cited by 70
Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities
Pasquel, F. J., Hendrick, A. M., Ryan, M. E., Cason, E., Ali, M. K., & Narayan, K. M. V. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815624109 · Cited by 69
Blood pressure control for diabetic retinopathy
Diana, V., Wang, X., Vedula, S. S., Marrone, M. T., Sleilati, G. G., Hawkins, B. S., & Frank, R. N. (2015) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.20151333t1 · Cited by 63
Glycemic Control and Development of Retinopathy in Youth-onset Insulin-dependent Diabetes Mellitus
Goldstein, D. E., Blinder, K. J., Ide, C. H., Wilson, R. J., Wiedmeyer, H.-M., Little, R. R., England, J. D., Eddy, M. C., Hewett, J. E., & Anderson, S. K. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31516-2 · Cited by 61
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s90 · Cited by 55
The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema
Brown, G. C., Brown, M. M., Turpcu, A., & Rajput, Y. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.03.032 · Cited by 35
Hooper, P., Boucher, M. C., Cruess, A. F., Dawson, K. G., Delpero, W., Greve, M. D. J., Kožoušek, V., Lam, W., & Maberley, D. (2012) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2012.01.022 · Cited by 35
Progression of Diabetic Retinopathy and Maculopathy After Phacoemulsification Surgery
Rashid, S., & YOUNG, L. H. Y. (2009) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e3181c555cf · Cited by 19
Haig, J., Barbeau, M., & Ferreira, A. (2016) · Journal of Medical Economics · doi:10.3111/13696998.2016.1154566 · Cited by 16
Cited by
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
Self-citationScreening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Current understanding of the molecular and cellular pathology of diabetic retinopathy
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00451-4 · Cited by 645
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Zaharia, O. P., Strassburger, K., Strom, A., Bönhof, G. J., Karusheva, Y., Antoniou, S., Bódis, K., Markgraf, D. F., Burkart, V., Müssig, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30187-1 · Cited by 600
Metadata
- Authors
- Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-02-13
- Volume
- 40
- Issue
- 3
- Pages
- 412-418
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2590312224
- Cited by
- 940
- References
- 59
- FWCI
- 59.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.